PDR MEMBER LOGIN:
  • PDR Search

    Required field
  • PDR Drug Communications are designed to improve the speed and efficacy of the delivery of PDR Drug Alerts, Recalls and Approvals to physicians, prescribers, and their staff.

    Below are the PDR Drug Communications that have been issued by PDR Network. To view the communication details, click on the Medication name.

    If you have trouble accessing Alert details, click to get the latest version of the free Adobe Acrobat Reader software for your computer.

    Filter results by:

    Results 1-20 of 132

    September 16, 2022 Drug Alert: Opioid Analgesics - FDA Required REMS for Serious Drug Risks

    Analgesic Opioids

    Purdue Pharma LP

    May 19, 2022 Drug Alert: Important Correction of Drug Information

    Copiktra®

    Secura Bio, Inc.

    March 07, 2022 Drug Alert: Important Reminder

    Clozapine REMS

    Various Clozapine Manufacturers

    February 28, 2022 Drug Alert: Important Reminder

    Clozapine REMS

    Various Clozapine Manufacturers

    February 28, 2022 Drug Alert: Important Reminder

    Clozapine REMS

    Various Clozapine Manufacturers

    February 18, 2022 Drug Alert: Important Drug Warning

    Kimmtrak® (tebentafusp-tebn)

    Immunocore LLC.

    December 16, 2021 Drug Alert: Important Drug Warning

    Xeljanz® (tofacitinib)

    Pfizer

    December 02, 2021 Drug Alert: Important Drug Warning

    Alecensa® (alectinib)

    Genentech, Inc.

    November 18, 2021 Drug Alert: Important Drug Warning

    Mycophenolate

    Various Mycophenolate Applicants

    October 27, 2021 Drug Alert: Important Prescribing Information

    Activase® (alteplase)

    Genentech, Inc.

    September 29, 2021 Drug Alert: Important Drug Warning

    Paxil (paroxetine) tablets and Paxil CR (paroxetine) extended-release tablets

    Apotex Corp.

    September 27, 2021 Drug Alert: Important Drug Warning

    Fluoxetine Tablets, 60 mg

    Almatica Pharma

    September 17, 2021 Drug Alert: Opioid Analgesics - FDA Required REMS for Serious Drug Risks

    Analgesic Opioids

    Purdue Pharma LP

    September 10, 2021 Drug Alert: Important Prescribing Information

    Actemra® (tocilizumab)

    Genentech, Inc.

    August 23, 2021 Drug Alert: FDA Required Updated REMS Safety Information

    Clozapine REMS

    Various Clozapine Manufacturers

    August 23, 2021 Drug Alert: FDA Required Updated REMS Safety Information

    Clozapine REMS

    Various Clozapine Manufacturers

    August 23, 2021 Drug Alert: FDA Required Updated REMS Safety Information

    Clozapine REMS

    Various Clozapine Manufacturers

    August 20, 2021 Drug Alert: FDA-REQUIRED REMS SAFETY INFORMATION

    Blenrep (belantamab mafodotin-blmf)

    GlaxoSmithKline LLC

    August 12, 2021 Drug Alert: FDA Required Updated REMS Safety Information

    Clozapine REMS

    Various Clozapine Manufacturers

    July 15, 2021 Drug Alert: Important Prescribing Information

    Valcyte® (valganciclovir)

    Genentech, Inc.

    Results 1-20 of 132